Cargando…
Inflammatory Myofibroblastic Tumor: A Rare Presentation and an Effective Treatment with Crizotinib
Inflammatory myofibroblastic tumor (IMT) is a rare entity of neoplastic origin. It usually occurs in children and adolescents and most commonly involves pulmonary and gastrointestinal sites. Here, the authors present two cases; one is the nine months old boy with a subcutaneous IMT in the left tempo...
Autores principales: | Khalil, Sumaira, Ghafoor, Tariq, Raja, Amna Kaneez Fatima |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7368202/ https://www.ncbi.nlm.nih.gov/pubmed/32695536 http://dx.doi.org/10.1155/2020/6923103 |
Ejemplares similares
-
Effectiveness of Crizotinib for Inflammatory Myofibroblastic Tumor with ALK mutation
por: Ogata, Misato, et al.
Publicado: (2018) -
A Rare Presentation of Inflammatory Myofibroblastic Tumor in the Nasolabial Fold
por: Alshammari, Hind K., et al.
Publicado: (2019) -
Malignant inflammatory myofibroblastic tumor: a rare case presentation
por: Spafford, Megan, et al.
Publicado: (2022) -
Epithelioid Inflammatory Myofibroblastic Sarcoma With Poor Response to Crizotinib: A Case Report
por: Aminimoghaddam, Soheila, et al.
Publicado: (2023) -
Crizotinib combined with bronchoscopic interventional treatment in ALK-positive inflammatory myofibroblastic tumor of left main stem bronchus: a case report
por: Zhang, Peng, et al.
Publicado: (2023)